Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020473 (
hyperlipidemia
)
15,891
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cholesteryl ester transfer protein (CETP) mediates the interlipoprotein exchange of cholesteryl ester (CE) and triglyceride. A second plasma protein,
lipid transfer inhibitor protein
(
LTIP
), binds to lipoproteins and inhibits CETP activity by displacing CETP from the lipoprotein surface. Since free fatty acids (FFAs) enhance the binding of CETP to lipoproteins, we have examined the possible role of FFAs in modulating
LTIP
activity. Partially purified CETP,
LTIP
, and lipoproteins were incubated with 0 to 30 mumol/L sodium oleate, and the transfer of CE between a labeled donor lipoprotein and a given acceptor lipoprotein was measured. Without
LTIP
, oleate stimulated CETP-mediated CE transfer between VLDL, LDL, and HDL up to threefold. This stimulation was unique in both magnitude and oleate concentration dependence for each donor-acceptor lipoprotein pair. In contrast to CETP activity, in transfer reactions involving LDL or VLDL as donor,
LTIP
activity was suppressed (> 80%) by 10 to 15 mumol/L oleate.
LTIP
activity in transfer reactions with HDL as donor was less sensitive. Similar results to these were observed when lipid transfer reactions were measured in the total lipoprotein fraction isolated from FFA-enriched plasma. The FFA content of lipoproteins was strongly influenced by the concentration of FFA in plasma; lipoprotein FFA levels sufficient to suppress
LTIP
activity by 50% to 100% were achieved in plasma containing 0.8 to 1.0 mmol/L FFA. We conclude that
LTIP
may be functionally inactive during periods of transient elevations of plasma FFA levels, such as during postprandial
lipemia
or overnight fasting, or chronically suppressed in disease states in which plasma FFA levels are increased. The suppression of
LTIP
activity by FFA allows for maximum CETP-mediated lipid transfer between all lipoproteins, including lipid transfer reactions involving LDL that are normally preferentially suppressed by
LTIP
.
...
PMID:Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids. 940 91
Lipid transfer inhibitor protein
(
LTIP
) is a regulator of cholesteryl ester transfer protein (CETP) function. Factors affecting plasma
LTIP
levels are poorly understood. In humans, plasma
LTIP
is elevated in hypercholesterolemia. To define possible mechanisms by which
hyperlipidemia
modifies
LTIP
, we investigated the effects of hypercholesterolemic diets on plasma
LTIP
and mRNA levels in experimental animals. The hamster, which naturally expresses CETP, was shown to express
LTIP
. Hamster
LTIP
mRNA, exclusively detected in the liver, defined a predicted
LTIP
protein that is 69% homologous to human, with an isoelectric point of 4.15 and Mr = approximately 16.4 kDa.
Hyperlipidemia
induced by feeding hydrogenated coconut oil, cholesterol, or both lipids increased plasma
LTIP
mass up to 2.5-fold, with
LTIP
mass correlating strongly with plasma cholesterol levels. CETP mass was similarly affected by these diets. In contrast, these diets reduced
LTIP
hepatic mRNA levels by >50%, whereas CETP mRNA was increased. Similar results for both CETP and
LTIP
were also observed in cholesterol-fed rabbits. In conclusion, we report in hamster and rabbit that dietary lipids regulate
LTIP
. Diet-induced hypercholesterolemia markedly increased plasma
LTIP
mass while concomitantly depressing
LTIP
gene expression. CETP and
LTIP
have distinct responses to dietary lipids.
...
PMID:Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia. 1900 50